K180229 is an FDA 510(k) clearance for the RESCAN 700, CALLISTO eye. This device is classified as a Tomography, Optical Coherence (Class II - Special Controls, product code OBO).
Submitted by Carl Zeiss Meditec, AG (Jena, DE). The FDA issued a Cleared decision on January 11, 2019, 350 days after receiving the submission on January 26, 2018.
This device falls under the Ophthalmic FDA review panel. Regulated under 21 CFR 886.1570. Viewing, Imaging, Measurement, And Analysis Of Ocular Structures. Diagnostic Device To Aid In The Detection And Management Of Various Ocular Diseases..